Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Alex Z Fu

2PUBLICATIONS

6CO-AUTHORS

Gene and molecular therapyMedical molecular engineering of nucleic acids and proteins

Featured researcher

Get your video featured.

Publish with JoVE

Featured researcher

Get your video featured.

Publish with JoVE

Publications (2)

Sort by Publication Date:

|Nov 03, 2025

Healthcare resource utilization and costs in patients with multiple myeloma who received 1 to 3 prior lines of therapy, including a proteasome inhibitor and an immunomodulatory drug, and were exposed to and discontinued lenalidomide in the United States.

Sundar Jagannath, Akshay Kharat, Eric Chinaeke

|Nov 15, 2022

Patient characteristics associated with dose modifications for VRd among newly diagnosed multiple myeloma patients.

Tao Ran, Rohan Medhekar, Alex Z Fu

Pageof 1

Frequent Collaborators

1 joint publications

Sundar Jagannath

1 joint publications

Akshay Kharat

1 joint publications

Eric Chinaeke

1 joint publications

Matthew Perciavalle

1 joint publications

Stephen Huo

1 joint publications

Zaina P Qureshi

Frequent Collaborators

1 joint publications

Sundar Jagannath

1 joint publications

Akshay Kharat

1 joint publications

Eric Chinaeke

1 joint publications

Matthew Perciavalle

Top Related Videos

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on : Jul 15, 2015

See more related videos

Top Related Videos

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on : Jul 15, 2015

See more related videos